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e have analyzed the effects of latent TGF-
 
 
 
binding protein 2 (LTBP-2) and its fragments
on lung ﬁbroblast adhesion. Quantitative cell
adhesion assays indicated that ﬁbroblasts do not adhere
to full-length LTBP-2. Interestingly, LTBP-2 had dominant
disrupting effects on the morphology of ﬁbroblasts adhering
to ﬁbronectin (FN). Fibroblasts plated on LTBP-2 and FN
substratum exhibited less adherent morphology and displayed
clearly decreased actin stress ﬁbers than cells plated on
FN. These cells formed, instead, extensive membrane rufﬂes.
W
 
LTBP-2 had no effects on cells adhering to collagen type I.
Fibroblasts adhered weakly to the NH
 
2
 
-terminal fragment
of LTBP-2. Unlike FN, this fragment did not augment actin
stress ﬁber formation. Interestingly, the adhesion-mediating
and cytoskeleton-disrupting effects were localized to the
same NH
 
2
 
-terminal proline-rich region of LTBP-2. LTBP-2 and
its antiadhesive fragment bound to FN in vitro, and the anti-
adhesive fragment associated with the extracellular matrix
FN ﬁbrils. These observations reveal a potentially important
role for LTBP-2 as an antiadhesive matrix component.
 
Introduction
 
Latent TGF-
 
 
 
 binding protein 2 (LTBP-2) belongs to the
LTBP–fibrillin gene family, which contains LTBPs 1–4 and
fibrillins 1, 2 (Saharinen et al., 1999), and 3 (Genbank/
EMBL/DDBJ accession no. AY165864). These proteins are
ECM glycoproteins sharing similar overall domain structure.
They consist mainly of cysteine-rich EGF-like and 8-cysteine
(8-Cys) repeats. EGF-like repeats exist in a number of ECM
proteins, whereas 8-Cys repeats have so far only been found
in fibrillins and LTBPs. Cysteine-rich regions are frequently
interrupted by variable proline-rich regions in LTBPs, while
fibrillins contain only one such region.
Fibrillins were first identified as components of elastic
tissue microfibrils. Microfibrils consist, in addition to fi-
brillins, of several other proteins like microfibril-associated
glycoproteins (MAGPs) 1 and 2 (Rosenbloom et al., 1993).
Fibrillins are important for the structure of microfibrils,
as shown by mice expressing mutated fibrillin-1 forms
(Pereira et al., 1997; Kielty et al., 1998; Gayraud et al.,
2000). TGF-
 
 
 
s are secreted from cells as latent complexes
composed of the mature dimeric growth factor together
with its NH
 
2
 
-terminal latency-associated peptide (Saharinen
et al., 1999; Annes et al., 2003). The secretion of small
latent (SL) TGF-
 
 
 
 from the cells is augmented by LTBP-1
(Miyazono et al., 1991), and LTBP-1 directs this complex
to the ECM (Taipale et al., 1994). At least LTBP-1 has a
role in the activation of latent TGF-
 
 
 
 (Flaumenhaft et
al., 1993). LTBP-1 localizes to the fibrillin-containing
ECM microfibrils as well as to the pericellular cell surface–
associated  fibronectin (FN) fibrils (Taipale et al., 1996;
Isogai et al., 2003). The majority of LTBP-1 protein is
secreted from the cells without SL-TGF-
 
 
 
 (Taipale et al.,
1994), suggesting that LTBP-1 has novel functions, like
structural roles in the ECM.
After the identification of LTBP-1 (Kanzaki et al., 1990),
three other LTBPs have been cloned, namely LTBP-2, -3,
and -4 (Moren et al., 1994; Yin et al., 1995; Giltay et al.,
1997; Saharinen et al., 1998). LTBP-2 has been localized by
immunoelectron microscopy to the elastic microfibrils in
bovine tissues (Gibson et al., 1995). While LTBP-1, -3, and
-4 are true SL-TGF-
 
 
 
 binding proteins, LTBP-2 is unable
to bind SL-TGF-
 
 
 
 (Saharinen and Keski-Oja, 2000). In
addition, gene-targeted mice for LTBP-2 show early embry-
onic lethality (Shipley et al., 2000) differing from the
phenotypes of all TGF-
 
 
 
 (TGF-
 
 
 
1, -
 
 
 
2, and -
 
 
 
3) gene
knockout mice (Shull et al., 1992; Proetzel et al., 1995;
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Sanford et al., 1997). This indicates that at least LTBP-2 has
important functions not related to TGF-
 
 
 
.
Cell interactions with ECM components are a central,
regulated cascade of events both during embryo- and organ-
ogenesis and during later stages of life (Gumbiner, 1996).
Cells adhere to the ECM via cell surface receptors, often
via integrin receptors and RGD recognition sequences of
ECM proteins (Ruoslahti, 1996). FN (Vaheri and Ruo-
slahti, 1975) is the most widely studied example of an adhe-
sive ECM component. Earlier studies indicated that LTBP-2–
associated ECM components, such as fibrillin-1 and MAGP-2,
mediate cell adhesion, at least in part via their RGD
sequences (Sakamoto et al., 1996; Gibson et al., 1999).
LTBP-2 contains an RGD cell adhesion sequence, which led
us to explore the possible adhesive functions of LTBP-2 for
human lung fibroblasts. We chose lung fibroblasts for our
studies because lung is the major site of LTBP-2 expression
(Moren et al., 1994). These cells attached to a specific pro-
line-rich NH
 
2
 
-terminal fragment of LTBP-2, which did not,
however, contain the RGD sequence. Fibroblasts adhering
to this fragment did not spread appreciably or form actin
stress fibers. In contrast, this fragment exhibited a dominant
cytoskeleton formation–disrupting effect on fibroblasts.
LTBP-2 and especially its proline-rich NH
 
2
 
-terminal region
exerted modulatory effects on the actin cytoskeleton of fi-
broblasts and induced a less adherent phenotype. LTBP-2 is
thus a new member to the family of extracellular antiadhe-
sive glycoproteins.
 
Results
 
Production of LTBP-2 fragments
 
To explore the effects of LTBP-2 and its domains on cell
adhesion, we produced partially overlapping recombinant
protein fragments covering the whole LTBP-2 protein
(Fig. 1 A). The fragments were expressed either as histi-
dine-tagged fragments or as dimeric fusion proteins with
the constant region of immunoglobulin G to aid purifica-
tion. The reason for using the Ig tag was that the expres-
sion levels were generally higher, and some fragments were
more soluble when expressed as fusion proteins with a rela-
tively large IgG constant region than those with a small
histidine tag (not depicted). However, all the results ob-
tained with Ig-tagged proteins were confirmed with histi-
dine-tagged fragments.
All protein fragments were secreted from the cells, but
the expression levels varied. The larger fragments were, in
general, expressed at lower levels than the smaller ones.
Some proteins were prone to proteolysis by endogenous
proteases. This was noted with fragments containing the
proline-rich regions before the hybrid domain (fragments
L2-IV, L2-VII), and especially with COOH-terminal frag-
ments containing the proline-rich region (fragments L2-
XIII and L2–XIV) (Fig. 1 B), suggesting that the COOH
terminus of LTBP-2 is sensitive to proteases in intact, full-
length protein. A related cleavage has been described ear-
lier with corresponding LTBP-1 fragments (Unsöld et al.,
2001). Fragment L2-X containing the previously identified
protease-sensitive area (Hyytiäinen et al., 1998) was also
slightly degraded. The migration of fragment L2-X was
 
also anomalous in SDS-PAGE. The calculated molecular
mass of this dimeric fragment L2-X together with the Ig
tag is 
 
 
 
80 kD, but it migrated as an almost 200-kD band.
The reason for its aberrant migration in SDS-PAGE is un-
clear at present.
The histidine-tagged LTBP-2 fragments were purified by
metal chelate chromatography as described above. In addi-
tion to the fragments, there was occasionally an 
 
 
 
65-kD
contaminating protein, which copurified from CHO-condi-
tioned medium in metal chelate chromatography (Fig. 1 B,
lane L2-N*). It could be removed with gel filtration and was
Figure 1. Schematic representation of recombinant LTBP-2 
fragments. (A) Domain structure of full-length LTBP-2 (top). LTBP-2 
fragments were expressed as fusion proteins with IgG Fc region 
(middle) or as COOH-terminally histidine-tagged proteins (bottom). 
The domain map of each fusion protein is illustrated, as well as amino 
acid numbers of each construct. The characteristics of the domains 
are described below the figure. The COOH-terminal LTBP-3 fragment 
L3-C* (Penttinen et al., 2002) used as a control is also illustrated. The 
antiadhesive fragment L2-V is rectangled. (B) Analysis of expressed 
and purified LTBP-2 fragments by SDS-PAGE. Aliquots (2  g) of each 
expressed and purified LTBP-2 fragment were analyzed by 4–15% 
gradient PAGE in the presence of SDS under nonreducing conditions 
and visualized by Coomassie blue staining. The migration of molec-
ular mass standards (kD) is indicated on the left, and the designations 
of the fusion proteins on the top. Leftmost, control Fc protein (ctrl). 
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not responsible for the cell adhesion effects of the LTBP-2
fragments (not depicted).
 
Lung fibroblasts bind to an NH
 
2
 
-terminal 
fragment of LTBP-2
 
As LTBP-2 has a potential cell adhesion–mediating RGD se-
quence (Fig. 1 A) (Ruoslahti, 1996), we analyzed first the
properties of LTBP-2 and its recombinant fragments in cell
adhesion assays (Fig. 2 A) using FN as a control. Full-length
LTBP-2 did not display significant effects in the cell binding
assays with any of the coating concentrations used (Fig. 2 A
and not depicted). Unexpectedly, fibroblasts adhered to frag-
ment L2-IV, which contains the hybrid domain and the pre-
ceding proline-rich area (illustrated in Fig. 1). The number of
cells attaching to wells coated with this fragment was con-
stantly lower than that attached to FN-coated wells (maxi-
mally 
 
 
 
60% of the binding to FN).
To localize more exactly the fibroblast-binding region of
LTBP-2, we constructed and expressed two new Ig fusion
proteins, L2-V and L2-VI, covering the proline-rich variable
region before the hybrid domain, and the hybrid domain,
respectively. Cell culture plates were then coated with these
fragments, and cell adhesion assays were performed as de-
scribed in the previous section (Fig. 2 B). The cells adhered
to the wells coated with fragment L2-V in a concentration-
dependent manner, whereas no adhesion to fragment L2-VI
(containing the hybrid domain) was observed.
To confirm the results and to rule out the possibility that
the adherence would be caused by artificial dimer forma-
tion of Ig fusion proteins, we expressed, purified, and re-
peated the adhesion assays with histidine-tagged fragments
of LTBP-2 (Fig. 3). Two NH
 
2
 
-terminal fragments were
produced, a larger one, covering most of the NH
 
2
 
-terminal
half of LTBP-2 (L2-N*), and a short one (L2-V*), corre-
sponding to fragment L2-V. As expected, lung fibroblasts
adhered to both fragments in a concentration-depen-
dent manner. The fragments exhibited bell-shaped dose–
Figure 2. Fibroblasts bind to a proline-rich NH2-terminal fragment 
of LTBP-2. (A) Tissue culture 96-well plates were coated with the 
indicated fragments of LTBP-2 (20  g/ml), control Ig protein (right), 
FN (10  g/ml), or BSA only (left). Cell adhesion assays were per-
formed in triplicate wells using fetal lung fibroblasts. The numbers of 
attached cells were compared with the value of cells attached to FN 
(100%). Fragment L2-IV mediated cell attachment (*, P   0.05), 
while full-length LTBP-2 was negative. (B) To further define the cell 
adhesion–mediating domain, cell adhesion was tested with two sub-
fragments spanning L2-IV. Of these, the proline-rich area, fragment 
L2-V, mediated cell attachment in a concentration-dependent manner.
Figure 3. LTBP-2 fragments have concentration-dependent, bell-
shaped effect on fibroblast adhesion. To observe the effects of 
histidine-tagged NH2-terminal LTBP-2 fragments on cell adhesion, 
tissue culture plates were coated with the indicated concentrations 
of fragments L2-N* (A) or L2-V* (B), and the cell adhesion assay was 
performed. Fibroblasts adhered to both fragments in a concentration-
dependent manner. The binding decreased with the higher concen-
trations of both fragments, yielding bell-shaped curves. 
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response effects: after reaching a critical coating concentra-
tion, cell adhesion decreased.
 
NH
 
2
 
-terminal fragments of LTBP-2 induce modest cell 
spreading, but not actin stress fiber formation
 
To characterize the effects of the fibroblast adhesion–medi-
ating LTBP-2 fragments on cell morphology, we visualized
actin cytoskeletons with fluorescently labeled phalloidin af-
ter plating the cells on coverslips coated with LTBP-2 or its
fragments (Fig. 4 A) and quantified cell spreading on these
substrates (Fig. 4 B). The coating concentrations of frag-
ments were chosen for optimal cell binding as analyzed in
Fig. 3. Cells seeded on BSA-coated coverslips spread very
poorly and did not form stress fibers. Cells seeded on full-
length LTBP-2 spread even less (Fig. 4 B). Filamentous ac-
tin localized to patches in the cytoplasm, but no distinct
structures could be observed. Even lower concentrations of
LTBP-2 did not induce cell spreading (not depicted). Cells
plated on coverslips coated with NH
 
2
 
-terminal LTBP-2
fragments spread slightly more, but significantly less than on
FN (Fig. 4 B). Phalloidin staining was partially localized to
the cytoplasm, but also to the membrane ruffles in the cell
periphery (Fig. 4 A). Cells attached to LTBP-2 fragments
did not form actin stress fibers.
 
LTBP-2 and its fragments have dominant actin 
cytoskeleton and focal adhesion–disrupting 
effects in fibroblasts adhering to FN
 
To analyze whether LTBP-2 or its fragments can affect cell
adhesion and actin cytoskeleton organization in cells adher-
ing to FN, we performed quantitative adhesion assays and
phalloidin stainings as above. In preliminary experiments,
we noted that simultaneous coating of the plates with both
proteins at the concentrations used decreased the coating
efficiency of FN. This was determined by semiquantita-
tive immunoblotting analysis of coverslip/cell culture plate–
bound FN (unpublished data). To maintain constant levels
of coverslip-bound FN, the coverslips were first coated with
FN and the binding sites were saturated with BSA. Subse-
quently, the indicated LTBP-2 fragments were allowed to
bind onto coverslips in PBS. Due to this sequence in coat-
ing, only the effects of the proteins bound either to FN or
nonspecifically to BSA were detected in the attachment as-
says (Fig. 5). We found that full-length LTBP-2 bound non-
specifically to all coverslips and plates under these coating
conditions, even to BSA (not depicted).
Full-length LTBP-2 had a relatively minor effect (
 
 
 
10%
decrease) on the number of cells adhering to FN substratum
(Fig. 5 A), and statistical values were P 
 
  
 
0.05, when cell ad-
hesion was compared with cells adhering to FN. As LTBP-2
proved later to have antiadhesive effects (see next para-
graph), we compared its effects to tenascin-C, a known anti-
 
Figure 4.
 
Cells bound to LTBP-2 fragments spread slightly, but do 
not form actin stress fibers.
 
 (A) Morphological analysis. To character-
ize the actin cytoskeletons of the cells attached to LTBP-2 fragments, 
glass coverslips were coated with BSA, FN (10 
 
 
 
g/ml), full-length 
LTBP-2 (20 
 
 
 
g/ml), or histidine-tagged fragments L2-N* (10 
 
 
 
g/ml) 
or L2-V* (5 
 
 
 
g/ml). Fibroblasts were allowed to attach for 90 min, 
followed by fixation and staining with phalloidin-TRITC. Cells plated 
on LTBP-2 did not spread or form stress fibers. Cells bound to LTBP-2 
fragment–coated plates spread more efficiently than cells on BSA, but 
did not form stress fibers, as cells on FN. Bar, 20 
 
 
 
m. (B) Quantifica-
tion of cell spreading. Cells were plated and processed as in A, and 
cell spreading was quantified from three randomly selected fields of 
each coverslip as described in the Materials and methods. Cells spread 
to some extent on NH
 
2
 
-terminal fragments of LTBP-2, whereas no 
cell spreading was observed in cells plated on full-length LTBP-2 
(*, P 
 
  
 
0.05, compared with cell spreading on FN). 
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adhesive protein (Chiquet-Ehrismann et al., 1988; Huang et
al., 2001). The effects of tenascin-C were of the same mag-
nitude as those of LTBP-2.
Next, we investigated the effects of LTBP-2 on actin cyto-
skeletons of cells attaching to FN. Full-length LTBP-2 and
its NH
 
2
 
-terminal fragments had a dominant actin stress fi-
ber formation–disrupting effect on fibroblasts when com-
pared with cells plated on FN alone (Fig. 5 B). Actin stain-
ing was mainly localized to the cell periphery, including
membrane ruffles and patch-like structures at the extrem-
ities of the cells, resembling very much the cells plated on
LTBP-2 fragments only (compare with Fig. 4), whereas cells
plated on FN formed extensive stress fibers. The effect
resembled that of tenascin-C. In addition, cells cultured on
LTBP-2/FN substratum were less spread than control cells
(Fig. 6 A). The COOH-terminal control fragment L3-C*
derived from LTBP-3 (Penttinen et al., 2002) did not ex-
hibit any detectable effects on cell morphology or actin cyto-
skeleton formation (Fig. 5 B).
Focal adhesions are another important cellular structure
for cell adhesion. We explored the effects of LTBP-2 on focal
adhesions of cells adhering to FN by localizing two well-char-
acterized focal adhesion proteins, vinculin and paxillin (Petit
and Thiery, 2000). Focal adhesions formed efficiently in cells
adhering to FN substratum (Fig. 5 C, left). In contrast, focal
adhesion formation was disrupted by LTBP-2 (Fig. 5 C,
right). Vinculin and paxillin were mostly cytoplasmic, and no
distinct structures could be observed. A small portion of the
Figure 5. LTBP-2 and its fragments have a dominant actin cytoskeleton formation–disrupting effect on fibroblast spreading on FN. 
(A) Comparison with tenascin-C. Plastic cell culture plates were coated first with FN (10  g/ml), and the free protein binding sites were saturated 
with BSA. The FN-coated plates were then incubated with LTBP-2 or tenascin-C at the indicated concentrations ( g/ml). The plates were 
washed, and quantitative cell adhesion assays were performed. (B) Morphological analysis. Glass coverslips were coated first with FN (10  g/ml), 
and the free protein binding sites were saturated with BSA. FN-coated coverslips were then incubated with LTBP-2, control LTBP-3 fragment 
L3-C*, tenascin-C (20  g/ml), or fragments L2-N* (10  g/ml) or L2-V* (5  g/ml). Fibroblasts were then allowed to attach and spread for 90 min, 
followed by fixation and staining with phalloidin-TRITC. Note that actin stress fiber formation was decreased in cells grown on coverslips 
treated with LTBP-2, its fragments, and tenascin-C. Fragment L3-C* had no effect. Bar, 20  m. (C) Effects on focal adhesions. Glass coverslips 
were coated with FN and incubated with LTBP-2 or PBS (concentrations as in B). The cells were plated and fixed as in B, after which vinculin 
and paxillin were detected by indirect immunofluorescence. Both proteins localized to focal adhesions in control cells, whereas focal adhesions 
were missing from cells attaching on FN/LTBP-2 substratum. Bar, 20  m. 
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staining was in the tips of the cell extensions and membrane
ruffles in a manner similar to actin staining. These findings
further support the hypothesis that LTBP-2 acts as an antiad-
hesive protein that decreases fibroblast adhesion.
 
Antiadhesive effect of LTBP-2 is concentration 
dependent
 
We explored next the concentration dependency of the anti-
adhesive effect of LTBP-2. Glass coverslips were coated with
a constant concentration of FN, and subsequently with in-
creasing concentrations of LTBP-2 or fragment L2-N* or
L2-V*. The cells were stained for actin 90 min after plating.
Cells were then observed in fluorescence microscopy and the
cell spreading was quantified. Low concentrations of LTBP-2
(1.25 
 
 
 
g/ml) had only minor effects (Fig. 6 A). With in-
creasing concentrations of LTBP-2, cell spreading decreased
steadily (Fig. 6 A, the lowermost panel), as well as the num-
ber of cells forming stress fibers (Fig. 6 B). With the highest
LTBP-2 concentration used (20 
 
 
 
g/ml), the cells did not
form any stress fibers and spread even less than cells on BSA-
Figure 6. Antiadhesive effects of LTBP-2 
and its fragments are concentration 
dependent. (A) Concentration depen-
dency analysis. Glass coverslips were 
coated with constant concentration of 
FN (10  g/ml). Nonspecific binding sites 
were saturated with BSA, and the cover-
slips were incubated with increasing 
concentrations of LTBP-2 or its fragments 
L2-N* and L2-V*. Fibroblasts plated on 
BSA only served as a control. Fibroblasts 
were fixed 90 min after plating and 
stained for actin. Cells lost their adherent 
morphology when the concentrations of 
LTBP-2 or its fragments were increased. 
Bottom, quantification of cell spreading. 
Cell spreading was quantified from the 
coverslips (three independent fields). 
Note the differences in maximal effects 
of LTBP-2 and its fragments. (B) Compar-
ison of LTBP-2 and tenascin-C effects on 
actin stress fiber formation. Actin stress 
fiber formation of cells was quantified 
from coverslips treated with increasing 
concentrations of LTBP-2 or tenascin-C. 
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coated substratum. These effects were similar to those ob-
tained by using tenascin-C (Fig. 6 B and not depicted). The
fragments L2-N* and L2-V* had quite similar concentra-
tion-dependent effects on cell morphology and actin cyto-
skeleton organization. However, the actin cytoskeleton– and
cell spreading–disrupting effects were less efficient than with
full-length LTBP-2 (Fig. 6 A). Unlike LTBP-2 itself, the
fragments reached a saturating concentration. The increase
of the coating concentration over a certain limit (2.5 
 
 
 
g/ml
with L2-N* and 1.25 
 
 
 
g/ml with L2-V*) did not further in-
hibit cell spreading or prevent further actin cytoskeleton or-
ganization (compare with LTBP-2 panel).
 
LTBP-2 and its antiadhesive fragments bind to FN
 
To gain an insight into the mechanisms of the antiadhesive
property, we analyzed whether LTBP-2 or its antiadhesive
fragments could bind directly to FN or collagen type I. For
this purpose, we established an enzyme-linked immunosor-
bent assay. Plates of 96 wells were first coated with increas-
ing concentrations of FN or collagen type I. Both proteins
coated the plates effectively under these conditions. Soluble
LTBP-2 or its fragments were then incubated in the wells in
a buffer containing BSA to prevent binding of LTBP-2 to
BSA. Bound LTBP-2 was detected with polyclonal affinity-
purified antibodies, and histidine-tagged fragments were de-
tected with monoclonal antibody recognizing the histidine
tag (Fig. 7 A). We observed that LTBP-2 and its fragments
L2-V* and L2-N* bound to FN in a concentration-depen-
dent and saturable manner, showing the specificity of bind-
ing (Fig. 7). In contrast, no binding of LTBP-2 to collagen
type I was observed.
 
LTBP-2 fragment L2-V* associates with the ECM
 
To analyze the extracellular localization of the NH
 
2
 
-terminal
antiadhesive fragments in overexpressing cells, we trans-
fected COS-7 cells and detected the expressed proteins by
indirect immunofluorescence using antibodies recognizing
the histidine tag. Secreted and either cell surface– or ECM-
bound histidine-tagged fragments (Fig. 8) were detected in
nonpermeated cells. To detect possible colocalization with
LTBP-2 fragments, we performed FN immunofluorescence
analysis of the same cells.
An antibody recognizing the histidine tag gave only faint
background staining in nontransfected control COS-7 cells
(Fig. 8, no transfection). The long fragment L2-N* localized
clearly to ECM fibers, colocalizing with FN. Part of the stain-
ing localized to the surface of cells (Fig. 8, L2-N*). Several
ECM binding regions have been localized to the correspond-
ing NH
 
2
 
-terminal region of LTBP-1 (Nunes et al., 1997; Un-
söld et al., 2001), and this pattern was therefore expected.
The antiadhesive fragment L2-V* localized to the extra-
cellular/pericellular matrix as well (Fig. 8, L2-V*). The
staining was more discontinuous than that of fragment
L2-N*. The staining clearly colocalized with FN in many,
but not all, locations.
Histidine-tagged fragment L2-X* was used as a control.
This fragment was detected at the surfaces of the cells (Fig. 8,
L2-X*), and no obvious colocalization with FN was detected.
COS-7 cells form relatively sparse extracellular matrices.
We have therefore repeated the assays using human lung fi-
broblasts. The results were similar (unpublished data), but
the transfection efficiencies of fibroblasts were very poor,
which prevented their use in the assays.
 
LTBP-2 is not antiadhesive for cells adhering 
to type I collagen
 
We determined next whether the actin cytoskeleton–disrupt-
ing effect of LTBP-2 would be specific for FN. For this pur-
pose, we coated coverslips with FN or collagen type I. Fibro-
blasts adhered more avidly to collagen type I than FN
Figure 7. Soluble LTBP-2 and its antiadhesive fragments bind to 
immobilized FN but not collagen type I. 96-well plates were coated 
with the indicated concentrations of FN (1 and 2) or collagen type I (3), 
after which nonspecific binding sites were saturated with BSA. LTBP-2 
(A), fragment L2-N* (B), or fragment L2-V* (C) (1 and 3, 2  g/ml; 
2, 0.5  g/ml) was then incubated in the wells for 1 h in a buffer 
containing BSA, to lower the background binding, after which the 
wells were washed. Bound LTBP-2 was detected with anti–LTBP-2 
antibodies and horseradish peroxidase–conjugated secondary anti-
body. LTBP-2 binds to FN in a concentration-dependent and saturable 
manner, whereas binding to collagen type I was not observed. 
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(unpublished data), permitting the use of lower concentra-
tions of it (Fig. 9). After saturation of nonspecific binding
sites with BSA, the coverslips were incubated with LTBP-2.
Under these conditions, LTBP-2 bound to both types of cov-
erslips, coated either with FN or collagen type I (not de-
picted). Cells adhered and formed stress fibers efficiently on
coverslips coated either with FN or collagen type I (Fig. 9).
However, in the presence of LTBP-2, the cells adhering to
FN were clearly less adherent and more rounded, whereas
LTBP-2 had no appreciable effects on cells adhering to col-
lagen type I (Fig. 9). We analyzed a wide range of FN and
collagen type I coating concentrations in the assays. The ef-
fects of LTBP-2 on cells adhering to FN were always promi-
nent, whereas effects on cells adhering to collagen type I were
negligible (unpublished data). These results indicated that
even though LTBP-2 is present on coverslips coated with
both FN and collagen type I, the cytoskeleton-disrupting ef-
fect of LTBP-2 is effective only for cells adhering to FN.
 
Discussion
 
LTBPs have generally been considered proteins that target
the effects of TGF-
 
 
 
 by augmenting its secretion from the
cells and targeting the latent complexes to appropriate sites
in the ECM (Saharinen et al., 1999). So far relatively few
other functions have been identified for LTBPs.
Fibrillins and other microfibril components, MAGP-2
(Gibson et al., 1999; Bax et al., 2003), mediate cell adhesion
via RGD sequences. Fibrillin-1 seems to mediate cell adhe-
sion also via non-RGD–dependent ways (Sakamoto et al.,
1996). LTBP-2 possesses a putative cell adhesion–mediating
RGD sequence, which led us to examine the effects of
LTBP-2, and especially its NH
 
2
 
 terminus, on cell adhesion.
Although full-length LTBP-2 did not mediate cell adhe-
sion, we found with Ig-tagged fragments an area that sup-
ported fibroblast binding in cell adhesion assays. This activ-
ity was localized to the NH
 
2
 
 terminus of LTBP-2 at the
variable region toward the COOH terminus from the sec-
ond EGF-like repeat and toward the NH
 
2
 
 terminus from the
hybrid domain. This region is rich in proline and positively
charged amino acids and has no defined domain properties.
The RGD sequence is not located at this area. When reana-
lyzing the results with histidine-tagged fragments, we ob-
served that cell adhesion to plates coated with recombinant
fragments of this region did not induce actin stress fiber for-
mation, even though the cells spread slightly more efficiently
Figure 8. Fragment L2-V associates with 
the ECM. COS-7 cells were transfected 
with the expression constructs (indicated 
on the left). 48 h after transfection, the 
cells were fixed. The expressed histidine-
tagged proteins were visualized by a 
mAb recognizing histidine tag and Texas 
red–conjugated anti–mouse secondary 
antibody. FN was visualized from the 
same cells with polyclonal rabbit anti-
FN antibodies and FITC-conjugated 
anti–rabbit antibodies. Both L2-N* and 
L2-V* fragments labeled fibrillar structures 
in the ECM. The staining colocalized 
partially with FN. Fragment L2-X*, which 
was used as a control, localized to cell 
surfaces, not to ECM fibers. Bar, 20  m. 
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than cells attaching onto BSA-coated coverslips. Actin was
localized in these cells to membrane ruffles. In addition, we
found that this region of LTBP-2 exhibited a concentration-
dependent, bell-shaped effect on cell adhesion. This sug-
gested that LTBP-2 might have antiadhesive properties and
guided us to explore possible combinatory effects of LTBP-2
and the adhesive ECM components FN and type I collagen
on cell adhesion and morphology.
We found that full-length LTBP-2, its NH
 
2
 
-terminal half,
and the proline-rich region (fragment L2-V) had dramatic
and dominant effects on the morphology of cells adhering to
FN. Both LTBP-2 and its NH
 
2
 
-terminal fragments prevented
stress fiber formation and caused actin redistribution to the
cell periphery. Cell spreading was also slightly impaired, and
the cells were more rounded, contributing to a less adherent
morphology. Accordingly, LTBP-2 disrupted focal adhesion
formation. Paxillin and vinculin, proteins localizing normally
to focal adhesions in adherent cells, localized mostly to patchy
structures in the cytoplasm and partially to membrane ruffles
in the presence of LTBP-2. Although the effect of LTBP-2 on
the number of attaching cells was minor, the cytoskeletal
changes were comparable to the other antiadhesive proteins
such as SPARC (Sage et al., 1989) and thrombospondin
(Murphy-Ullrich and Höök, 1989). This justifies the usage of
the term antiadhesive with LTBP-2.
The effect was characteristic of FN; cells adhering to type I
collagen exhibited normal cell morphology and actin cyto-
skeletons in the presence of LTBP-2. The tested proteins
comprise only a small number of adhesive ECM compo-
nents, and it will be of interest to analyze whether the antiad-
hesive effect of LTBP-2 is specific for example for certain in-
tegrins.
To obtain mechanistic insights for the antiadhesive effect
of LTBP-2, we established a binding assay for LTBP-2. We
noted that LTBP-2 binds to FN in a specific, saturable
manner but not to type I collagen. In addition, in binding
experiments with histidine-tagged fragments, we found that
the fragments with antiadhesive properties bound to FN as
well. Interestingly, the same fragments associated with the
ECM and colocalized with FN in cell cultures.
In contrast to NH
 
2
 
-terminal fragments, full-length LTBP-2
had no effects on cell adhesion, when coated separately. This
fact suggests that the cell adhesive function is cryptic in full-
length LTBP-2. However, FN-bound full-length LTBP-2
had antiadhesive effects on fibroblasts. We therefore propose
that the binding of LTBP-2 to FN may result in exposure of
cryptic, antiadhesive regions of LTBP-2.
We performed assays where we studied the concentration
dependency of the antiadhesive effect of LTBP-2 and its frag-
ments. Full-length LTBP-2 was the most effective in mediat-
ing antiadhesion, and the effects became more prominent
when increasing the concentration of LTBP-2. In contrast,
the fragments of LTBP-2 reached a saturation point. When
increasing the coating concentration above a critical point,
the effect was saturated. The maximal effects were not as
drastic as with full-length LTBP-2. This effect may result
from the saturation of LTBP-2 fragment binding sites in FN.
LTBP-2 fragments may act by binding to FN (compare Figs.
6 and 7) and blocking some adhesive epitopes in FN. Full-
length LTBP-2 may contain some additional binding sites/
mechanisms for antiadhesion.
The above-mentioned observations suggest that LTBP-2
has an ability to bind to FN localized to ECM and mask its
adhesive epitopes. Tenascin-C, a related antiadhesive ECM
component, has been proposed to exert its effects via this
mechanism. Tenascin-C binds FN and prevents syndecan-4
binding to it, causing a less adhesive phenotype in cells
(Huang et al., 2001). Interestingly, the effects of tenascin-C
were very similar to those of LTBP-2 in our studies. Major
antiadhesive effects were observed as decreased stress fiber
formation as well as cell spreading. Its effects on the number
of attaching cells were minor. In studies by others (Huang et
al., 2001) tenascin-C decreased the number of cells attaching
to mixed tenascin-C/FN substratum. The noted difference
possibly results from different experimental settings, such as
the number of cells used in assays.
Fibroblasts were observed to bind to the antiadhesive frag-
ment of LTBP-2. The morphology of the cells attaching to
the fragments was strikingly similar to cells attaching to FN/
LTBP-2 substratum. This suggests that the cell-binding ac-
tivity is related to its antiadhesive effect. Furthermore, the
fact that cells bind to the antiadhesive fragment suggests that
there might be a cell surface receptor recognizing this region
of LTBP-2. This hypothetical cell surface component could
act either in integrin adhesion complexes by sterically hin-
dering integrin binding to its ligand, or alternatively as sepa-
rate signaling receptors, affecting signal transduction and
preventing integrin activation and cell adhesion. This kind
of mechanism has been proposed for thrombospondin, an-
other antiadhesive ECM protein. The NH
 
2
 
-terminal frag-
ment of thrombospondin binds to calreticulin at the cell sur-
face, which affects the focal adhesion integrity (Goicoechea
Figure 9. LTBP-2 affects actin stress fibers only in cells adhering 
to FN, not to collagen type I. Glass coverslips were coated either 
with FN (10  g/ml) or with collagen type I (0.33  g/ml) as indicated, 
treated with BSA, and incubated with LTBP-2 (20  g/ml) as indicated. 
Fibroblasts were then plated, allowed to attach for 90 min, fixed, and 
stained for filamentous actin. Substratum-bound LTBP-2 completely 
prevented actin stress fiber formation in cells adhering to FN, but 
had no effect on cells adhering to collagen type I. Bar, 20  m. 
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et al., 2000). However, so far we have not been able to de-
tect such receptors.
We have observed recently that LTBP-2 acts as an adhe-
sion protein for cultured melanoma cells (Vehviläinen et al.,
2003). Melanoma cell adhesion leads to efficient cell spread-
ing, and the actin cytoskeletons appeared comparable to cells
adhered to FN. The adhesion was at least in part mediated
by 
 
 
 
3
 
 
 
1
 
 and, to a lesser extent, 
 
 
 
6
 
 
 
1
 
 integrins. Interestingly,
the melanoma cell adhesion site in LTBP-2 was localized to
the same proline-rich fragment L2-V, which was antiadhe-
sive for lung fibroblasts in the current study.
FN is a component of the so-called provisional matrices
during development and wound healing (Mosher, 1995).
We noted LTBP-2 to be antiadhesive of the tested ECM
components only for cells adhering to FN. Therefore, it is
possible that LTBP-2 has an antiadhesive role only for short
periods of time during development when FN exists in
ECM fibers. However, the antiadhesive role of LTBP-2
needs to be investigated in regard to the other adhesive
ECM components.
Antiadhesion or counteradhesion is a relatively rare, but
not extinct, phenomenon among ECM proteins (Chiquet-
Ehrismann, 1995). Examples of antiadhesive proteins in-
clude thrombospondin, tenascin, and SPARC (BM-40).
The modulation of cell adhesion is often related to cell mi-
gration. Filopodia and lamellipodia formation is crucial for
cell movement, and the actin cytoskeleton plays an impor-
tant role in these processes (Lauffenburger and Horwitz,
1996). As decreased actin stress fiber formation and in-
creased membrane ruffle formation caused by LTBP-2 and
its NH2-terminal fragment L2-V are consistent with the
promotion of cell migration, it is tempting to speculate that
the antiadhesive property of LTBP-2 is linked to the modu-
lation of fibroblast migration in the lung and other tissues
where LTBP-2 is expressed.
Materials and methods
Cell culture
Human embryonic lung fibroblasts (CCL-137; HEL-299, American Type Cul-
ture Collection) were maintained in MEM containing 10% fetal calf serum
(Life Technologies, Inc.), 100 IU/ml penicillin, and 50  g/ml streptomycin.
CHO cells were maintained in MEM, 10% fetal calf serum supplemented
with 0.2% BSA. Stable neomycin-resistant CHO clones were maintained in
MEM containing 0.2% BSA, 10% fetal calf serum, penicillin/streptomycin,
and 0.4 mg/ml G418 (Calbiochem). COS-7 cells were maintained in DME
supplemented with penicillin/streptomycin and 10% fetal calf serum.
Fibroblast adhesion assays
Tissue culture 96-well plates were coated with LTBP-2 or its fragments at
the concentrations indicated (50  l/well) either at 4 C for 16 h, or at 20 C
for 1 h in PBS (140 mM NaCl, 10 mM sodium phosphate, pH 7.4). Non-
specific cell adhesion was prevented by incubating the wells with 100  l
of 1% heat-treated (70 C for 1 h) BSA at 22 C for 1 h. The wells were
washed with PBS before the adhesion assays.
To detect the effects of LTBP-2 on cells adhering to FN or type I col-
lagen, the tissue culture plates or glass coverslips were first coated with FN
(10  g/ml) or type I collagen (0.33  g/ml). The proteins were prediluted
with PBS at room temperature before coating. Nonspecific binding sites
were then saturated with heat-treated BSA as before. Coverslips or plates
were then incubated with LTBP-2 (Hyytiäinen et al., 1998; Vehviläinen et
al., 2003), its fragments, or recombinant tenascin-C (Fischer et al., 1997) (a
gift of R. Chiquet-Ehrismann, Friedrich Miescher Institute, Basel, Switzer-
land) in PBS containing 1 mM CaCl2, 1 mM MgCl2 for 1 h. The plates were
then washed twice with PBS containing 1 mM CaCl2, 1 mM MgCl2.
Cells were detached from plates with trypsin-EDTA and suspended into
serum-free MEM. The cells were counted, spun down by centrifugation at
500 g for 5 min, and resuspended in serum-free medium (5   10
5 cells/ml).
Aliquots of the cell suspension (100  l; 5   10
4 cells) were plated in each
well. The plates were incubated in a humidified incubator at 37 C for 1 h.
Nonattached cells were removed by washing the wells twice with PBS. The
cells were then fixed and stained by filtered 0.1% Coomassie blue dissolved
in 30% methanol, 10% acetic acid. Subsequently, the cells were washed
extensively with 30% methanol/10% acetic acid and once with PBS. The
cells were lysed in 1% SDS, and A620 was measured. The results are pre-
sented as the mean value obtained from three different wells and compared
with the data obtained from cell adhesion to FN. Error bars represent the
standard error. Each experiment was performed at least three times.
Expression constructs
LTBP-2 fragments were expressed in stably transfected CHO cells as
dimeric NH2-terminal fusion proteins with the Fc portion of immunoglobu-
lin G as follows. Fragments of LTBP-2 cDNA were amplified by PCR using
Pfu or Pfu Turbo polymerase (Stratagene) with primers designed to main-
tain the open reading frame after the signal sequence and to continue to Fc
tail in signal pIg  (R&D Systems) vector. Primer sequences contained
HindIII (5  primers, all constructs except L2-X) or BamHI (3  primers, all
constructs except L2-VII and L2-VIII) restriction enzyme recognition sites
in the 5  end of the primers. Construct L2-VII and L2-VIII 3  primers con-
tained NotI recognition sites, and construct L2-X 5  primer contained KpnI
recognition site. L2 constructs contained as a fusion partner amino acids of
LTBP-2 as described and illustrated in Fig. 1 A. Amino acid numbering is
according to the translated cDNA sequence in Genbank/EMBL/DDBJ (ac-
cession no. Z37976). Control protein containing only the constant region
of human IgG was obtained by expression of vector pIg .
Histidine-tagged (six histidines) monomeric fragments were produced us-
ing pSecTagA vector (Invitrogen). cDNA fragments were produced by PCR
with the primers containing HindIII (5 ) and NotI (3 ) restriction enzyme rec-
ognition sites. L2-N* contains amino acids 161–843, L2-V* amino acids
429–550, and L2-X* amino acids 728–843 (also illustrated in Fig. 1 A).
PCR fragments were digested with the corresponding restriction en-
zymes and ligated to vector cut with the same enzymes. In constructs L2-
VII and L2-VIII and pSecTag constructs, adenosine nucleotides were first
inserted into the 3  ends of the PCR product with Taq polymerase, af-
ter which the PCR fragment was cloned into pGEM-T cloning vector
(Promega), from which the fragment was cloned to the target vector. All
constructs were sequenced to confirm that there were no PCR-derived mu-
tations. Histidine-tagged human LTBP-3 COOH-terminal fragment L3-C*
hL3/911–1153 was expressed and purified as described previously (Pent-
tinen et al., 2002).
Expression and purification of LTBP-2 fragments
Stable neomycin-resistant CHO cell clones were obtained by transfecting
the CHO cells with lipofectamine (Promega) with each expression con-
struct as described earlier (Hyytiäinen et al., 1998). 1 d after transfection,
the cells were changed to medium containing 1.5 mg/ml G418 (pIg ) or
0.5 mg/ml zeocin (pSecTag), after which the cells were maintained in the
selection medium for 2 wk. Stable drug-resistant cells were dilution cloned
to 96-well plates, and the expression of fusion protein was estimated by
dot blotting culture medium 1–2 wk after dilution cloning, using biotin-
ylated protein A (Sigma-Aldrich) or penta-his monoclonal antibody
(QIAGEN) as the first conjugate. The IgG fusion proteins were purified
from the conditioned medium with protein A affinity chromatography.
Histidine-tagged proteins were first precipitated with 35% (NH4)2SO4.
The precipitate was dissolved in the wash buffer (2 M urea, 300 mM NaCl,
50 mM Tris-HCl buffer, pH 7.2). The sample was loaded to Talon metal
chelate (CLONTECH Laboratories, Inc.) column. The column was washed
with the wash buffer, and the bound proteins were eluted with the same
buffer containing 100 mM imidazole. The buffer of the fractions contain-
ing the fusion proteins was then exchanged to PBS with Fast Desalting col-
umn HR 10/10 (Amersham Biosciences).
Fluorescence staining of the cells
For the immunofluorescence detection of FN and histidine-tagged proteins
in COS-7 cells, the cells were plated to six-well plates containing glass
coverslips. After reaching semiconfluency, the cultures were transfected
with the indicated expression constructs using Fugene 6 (Roche) according
to the manufacturer’s instructions. Cells were then maintained in normal
serum containing medium for 48 h before fixation.
The transfected cultures were washed with PBS. The cells were then
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times with PBS, and nonspecific binding sites were saturated by incubating
the cells with 5% BSA in PBS for 30 min. The coverslips were then treated
simultaneously with penta-his monoclonal antibody (QIAGEN) and anti-FN
rabbit polyclonal antibodies (Sigma-Aldrich), followed by Texas red–con-
jugated anti–mouse secondary antibody and fluorescein isothiocyanate–
conjugated anti–rabbit antibody (Jackson ImmunoResearch Laboratories).
After washes, the coverslips were mounted with Vectashield (Vector Labo-
ratories, Inc.).
For actin, vinculin, or paxillin staining of CCL-137 fibroblasts, subcon-
fluent cultures of cells were detached from tissue culture plates with
trypsin-EDTA and washed with serum-free medium. The cells were resus-
pended in serum-free MEM, containing the indicated proteins, and plated
onto acid-treated glass coverslips on six-well plate wells (10
5 cells/well).
Coverslips were coated before plating as indicated in the Fibroblast adhe-
sion assays section. After 90 min, the medium was removed, and the cells
were fixed with 3% paraformaldehyde in PBS for 20 min. The cells were
permeated with 0.1% TX-100 in PBS for 5 min, and nonspecific staining
was prevented by incubation with 5% BSA in PBS for 30 min. The cells
were finally stained for filamentous actin with tetramethyl rhodamine
isothiocyanate–conjugated phalloidin (Sigma-Aldrich) in PBS, 0.5% BSA.
To detect vinculin, the cells were incubated with anti-vinculin monoclonal
antibody (clone hVIN-1; Sigma-Aldrich), and to detect paxillin with anti-
paxillin monoclonal antibody (clone 349; BD Biosciences), and subse-
quently with Texas red–conjugated anti–mouse secondary antibody (Jack-
son ImmunoResearch Laboratories). After washes, the coverslips were
mounted with Vectashield.
Coverslips were observed with an Axioplan 2 microscope (Carl Zeiss
MicroImaging, Inc.) using 40  objective. Pictures were taken with Axio-
Cam HR (Carl Zeiss MicroImaging, Inc.) digital camera and AxioVision 3.1
(Carl Zeiss MicroImaging, Inc.) software. Brightness and contrast of the im-
ages were adjusted with Corel Photo-Paint (Corel Inc.) and decorated with
CorelDRAW (Corel Inc.) software.
Cell spreading and stress fiber quantification
Three independent and randomly chosen pictures were taken at 10  mag-
nification from actin-stained cells. The cell spreading was determined by
counting the area of each cell with the aid of Image-Pro software (Media
Cybernetics). The average of  100 cells was calculated, and cell spread-
ing on FN was set to one. The cell spreading values of cells on other sub-
strates was then compared with this value. Cells in contact with other cells
were excluded from the analysis. Actin stress fibers were quantified from
similar pictures by manually counting the percentage of cells forming
stress fibers on each substratum.
ELISA
Human plasma FN (Sigma-Aldrich) or native rat tail type I collagen (Up-
state Biotechnology) were diluted from stock solutions in acetic acid to
PBS to the indicated concentrations. MaxiSorp 96-well plates (Nunc) were
then coated with these proteins in PBS at 23 C for 1 h with shaking (as all
subsequent steps). Nonspecific protein binding sites were saturated with
3% BSA in PBS (23 C, 1 h). Wells were then washed once with incubation
buffer (PBS containing 1 mM CaCl2, 1 mM MgCl2, and 0.5% BSA). This
buffer was used in all subsequent washes and incubations. Purified LTBP-2
or fragment L2-N* or L2-V* were diluted and incubated in the wells for
1 h. The wells were next washed twice with the incubation buffer (5 min
each). Bound LTBP-2 was detected by incubating the wells with poly-
clonal affinity-purified antibody ab-L22 for 1 h (Hyytiäinen et al., 1998).
LTBP-2 fragments were detected with the penta-his monoclonal antibody.
The plates were washed twice (5 min each) and incubated with anti–rab-
bit or anti–mouse horseradish peroxidase–conjugated secondary antibody
for 30 min. The wells were finally washed (4   10 min) with the incuba-
tion buffer, and the bound immune complexes were detected with 1,2-
phenylenediamine dihydrochloride (DakoCytomation) according to the
manufacturer’s instructions. The reaction was terminated with H2SO4, and
the color reactions were measured with a spectrophotometer at wave-
length 450 nm.
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